ADH6 and ovarian cancer: Similarly, p53 null human ovarian cancer SKOV-3 cells were unaffected by treatment with ADH-6, but following transfection with R248W or R175H, the oligopyridylamide induced significant toxicity in the cells (Supplementary Fig. 12a–d).